Vaccination Yellow Fever
Yellov fever is the only disease where vaccination is required before entering several countries in Africa and South America. Yellow fever vaccination is recommended before entering several countries please refer to list of countries.
Vaccination: Yellow fever vaccine is a live virus vaccine, which has been used for several decades and is effective in protecting.
Protection: A single dose confers immunity lasting 10 years or more. Adults and children over 9 months can take this vaccine. A booster dose is needed every 10 years.
Side effects: Yellow fever vaccine generally has few side effects; fewer than 5% of vaccines develop mild headache, muscle pain, or other minor symptoms 5 to 10 days after vaccination.
Yellow fever Vaccination Resource: Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: An observational cohort study. Kernéis S, Launay O, Ancelle T, Iordache L, Naneix-Laroche V, Méchaï F, Fehr T, Leroy JP, Issartel B, Dunand J, Van der Vliet D, Wyplosz B, Consigny PH, Hanslik T. Arthritis Care Res (Hoboken). 2013 Apr 1. doi: 10.1002/acr.22021. [Epub ahead of print Recombinant Yellow Fever Viruses Elicit CD8(+) T Cell Responses and Protective Immunity against Trypanosoma cruzi. Nogueira RT, Nogueira AR, Pereira MC, Rodrigues MM, Neves PC, Galler R, Bonaldo MC. PLoS One. 2013;8(3):e59347. doi: 10.1371/journal.pone.0059347. Epub 2013 Mar 19 Yellow fever vaccination coverage following massive emergency immunization campaigns in rural Uganda, May 2011: a community cluster survey. Bagonza J, Rutebemberwa E, Mugaga M, Tumuhamye N, Makumbi I. BMC Public Health. 2013 Mar 7;13:202. doi: 10.1186/1471-2458-13-202 The Synergistic Effect of Combined Immunization with a DNA Vaccine and Chimeric Yellow Fever/Dengue Virus Leads to Strong Protection against Dengue. Azevedo AS, Gonçalves AJ, Archer M, Freire MS, Galler R, Alves AM. PLoS One. 2013;8(3):e58357. doi: 10.1371/journal.pone.0058357. Epub 2013 Mar 5 Travel Characteristics and Yellow Fever Vaccine Usage Among US Global TravEpiNet Travelers Visiting Countries with Risk of Yellow Fever Virus Transmission, 2009-2011. Jentes ES, Han P, Gershman MD, Rao SR, Larocque RC, Staples JE, Ryan ET; the Global TravEpiNet Consortium. Am J Trop Med Hyg. 2013 Mar 4. [Epub ahead of print Demographic profile of sylvatic yellow fever (SYF) in Brazil from 1973 to 2008. Câmara FP, de Carvalho LM, Gomes AL. Trans R Soc Trop Med Hyg. 2013 Feb 26. [Epub ahead of print Multifocal choroiditis following simultaneous hepatitis A, typhoid, and yellow fever vaccination. Escott S, Tarabishy AB, Davidorf FH. Clin Ophthalmol. 2013;7:363-5. doi: 10.2147/OPTH.S37443. Epub 2013 Feb 18 [Tourism, imported parasitic diseases, and their prevention]. Tumol'skaia NI, Zavoĭkin VD, Mazmanian MV, Plakhotnaia GA, Kurbatova IV, Zelia OP, Gutova VP. Med Parazitol (Mosk). 2012 Oct-Dec;(4):3-7. Russian. Vaccine Platforms to Control Arenaviral Hemorrhagic Fevers. Carrion R Jr, Bredenbeek P, Jiang X, Tretyakova I, Pushko P, Lukashevich IS. J Vaccines Vaccin. 2012 Nov 20;3(7). doi:pii: 1000160 Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine. Bao H, Ramanathan AA, Kawalakar O, Sundaram SG, Tingey C, Bian CB, Muruganandam N, Vijayachari P, Sardesai NY, Weiner DB, Ugen KE, Muthumani K. Viral Immunol. 2013 Feb;26(1):75-83. doi: 10.1089/vim.2012.0061 Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010. Breugelmans JG, Lewis RF, Agbenu E, Veit O, Jackson D, Domingo C, Böthe M, Perea W, Niedrig M, Gessner BD, Yactayo S; YF AEFI group. Vaccine. 2013 Apr 3;31(14):1819-29. doi: 10.1016/j.vaccine.2013.01.054. Epub 2013 Feb 7 17DD yellow fever vaccine: A double blind, randomized clinical trial of immunogenicity and safety on a dose-response study. Martins RM, Maia MD, Farias RH, Camacho LA, Freire MS, Galler R, Yamamura AM, Almeida LF, Lima SM, Nogueira RM, Sá GR, Hokama DA, de Carvalho R, Freire RA, Filho EP, Leal MD, Homma A. Hum Vaccin Immunother. 2013 Jan 30;9(4). [Epub ahead of print Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response. Blom K, Braun M, Ivarsson MA, Gonzalez VD, Falconer K, Moll M, Ljunggren HG, Michaëlsson J, Sandberg JK. J Immunol. 2013 Mar 1;190(5):2150-8. doi: 10.4049/jimmunol.1202234. Epub 2013 Jan 21 Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques. Martins MA, Bonaldo MC, Rudersdorf RA, Piaskowski SM, Rakasz EG, Weisgrau KL, Furlott JR, Eernisse CM, Veloso de Santana MG, Hidalgo B, Friedrich TC, Chiuchiolo MJ, Parks CL, Wilson NA, Allison DB, Galler R, Watkins DI. PLoS One. 2013;8(1):e54434. doi: 10.1371/journal.pone.0054434. Epub 2013 Jan 15 [ Yellow fever epidemic threatens refugee camps in western Sudan]. Jaenson T. Lakartidningen. 2012 Nov 28-Dec 4;109(48):2231-2. Swedish. No abstract available. Yellow fever epizootics in non-human primates, São Paulo state, Brazil, 2008-2009. Moreno ES, Spinola R, Tengan CH, Brasil RA, Siciliano MM, Coimbra TL, Silveira VR, Rocco IM, Bisordi I, de Souza RP, Petrella S, Pereira LE, Maeda AY, da Silva FG, Suzuki A. Rev Inst Med Trop Sao Paulo. 2013 Jan-Feb;55(1):45-50 Mortality and morbidity among military personnel and civilians during the 1930s and World War II from transmission of hepatitis during yellow fever vaccination: systematic review. Thomas RE, Lorenzetti DL, Spragins W. Am J Public Health. 2013 Mar;103(3):e16-29. doi: 10.2105/AJPH.2012.301158. Epub 2013 Jan 17. Review Optimization of the cutoff value for a commercial anti-dengue virus IgG immunoassay. Marrero-Santos KM, Beltrán M, Carrión-Lebrón J, Sanchez-Vegas C, Hamer DH, Barnett ED, Santiago LM, Hunsperger EA. Clin Vaccine Immunol. 2013 Mar;20(3):358-62. doi: 10.1128/CVI.00429-12. Epub 2013 Jan 9 Active assessment of adverse events following yellow fever vaccination of persons aged 60 years and more. Miyaji KT, Luiz AM, Lara AN, do Socorro Souza Chaves T, Piorelli RD, Lopes MH, Sartori AM. Hum Vaccin Immunother. 2013 Jan 4;9(2). [Epub ahead of print Human endogenous retroviruses and cancer prevention: evidence and prospects. Cegolon L, Salata C, Weiderpass E, Vineis P, Palù G, Mastrangelo G. BMC Cancer. 2013 Jan 3;13:4. doi: 10.1186/1471-2407-13-4 First
To top Back to list of vaccination Home Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News
TraveldoctorOnline 2001 Disclaimer webmaster The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.